Hormone withdrawal-associated symptoms with ethinylestradiol 20 μg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 μg/desogestrel 150 μg (21/7 regimen).
Saved in:
| Title: | Hormone withdrawal-associated symptoms with ethinylestradiol 20 μg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 μg/desogestrel 150 μg (21/7 regimen). |
|---|---|
| Authors: | Bitzer J; Department of Obstetrics and Gynecology, University Hospital of Basel, Basel, Switzerland., Banal-Silao MJ; University of the Philippines College of Medicine, Manila, Philippines., Ahrendt HJ; Praxis für Frauenheilkunde, Klinische Forschung und Weiterbildung (Clinical Research and Further Education), Magdeburg, Germany., Restrepo J; Centro de Investigación Clínica, Clinica Medellin Poblado, Medellin, Colombia., Hardtke M; Global Clinical Development Operations, Bayer Pharma AG, Berlin, Germany., Wissinger-Graefenhahn U; Global Medical Affairs Women's Healthcare, Bayer Pharma AG, Berlin, Germany., Trummer D; Clinical Statistics Europe, Bayer Pharma AG, Berlin, Germany. |
| Source: | International journal of women's health [Int J Womens Health] 2015 May 18; Vol. 7, pp. 501-9. Date of Electronic Publication: 2015 May 18 (Print Publication: 2015). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101531698 Publication Model: eCollection Cited Medium: Print ISSN: 1179-1411 (Print) Linking ISSN: 11791411 NLM ISO Abbreviation: Int J Womens Health Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1179-1411 |
|---|---|
| DOI: | 10.2147/IJWH.S77942 |
